Literature DB >> 25845499

Preservation of high glycolytic phenotype by establishing new acute lymphoblastic leukemia cell lines at physiologic oxygen concentration.

Michael A Sheard1, Matthew V Ghent2, Daniel J Cabral3, Joanne C Lee4, Vazgen Khankaldyyan5, Lingyun Ji6, Samuel Q Wu7, Min H Kang8, Richard Sposto9, Shahab Asgharzadeh10, C Patrick Reynolds11.   

Abstract

Cancer cells typically exhibit increased glycolysis and decreased mitochondrial oxidative phosphorylation, and they continue to exhibit some elevation in glycolysis even under aerobic conditions. However, it is unclear whether cancer cell lines employ a high level of glycolysis comparable to that of the original cancers from which they were derived, even if their culture conditions are changed to physiologically relevant oxygen concentrations. From three childhood acute lymphoblastic leukemia (ALL) patients we established three new pairs of cell lines in both atmospheric (20%) and physiologic (bone marrow level, 5%) oxygen concentrations. Cell lines established in 20% oxygen exhibited lower proliferation, survival, expression of glycolysis genes, glucose consumption, and lactate production. Interestingly, the effects of oxygen concentration used during cell line initiation were only partially reversible when established cell cultures were switched from one oxygen concentration to another for eight weeks. These observations indicate that ALL cell lines established at atmospheric oxygen concentration can exhibit relatively low levels of glycolysis and these levels are semi-permanent, suggesting that physiologic oxygen concentrations may be needed from the time of cell line initiation to preserve the high level of glycolysis commonly exhibited by leukemias in vivo.
Copyright © 2015. Published by Elsevier Inc.

Entities:  

Keywords:  Glycolysis; Oxygen; Proliferation

Mesh:

Substances:

Year:  2015        PMID: 25845499      PMCID: PMC8219348          DOI: 10.1016/j.yexcr.2015.03.024

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  33 in total

1.  Cancer cell line identification by short tandem repeat profiling: power and limitations.

Authors:  Walther Parson; Romana Kirchebner; Roswitha Mühlmann; Kathrin Renner; Anita Kofler; Stefan Schmidt; Reinhard Kofler
Journal:  FASEB J       Date:  2005-01-06       Impact factor: 5.191

2.  Dimethyl sulfoxide potentiates death receptor-mediated apoptosis in the human myeloid leukemia U937 cell line through enhancement of mitochondrial membrane depolarization.

Authors:  Jan Vondrácek; Karel Soucek; Michael A Sheard; Katerina Chramostová; Zdenek Andrysík; Jirina Hofmanová; Alois Kozubík
Journal:  Leuk Res       Date:  2005-07-05       Impact factor: 3.156

3.  In vitro testing of chemosensitivity in physiological hypoxia.

Authors:  Rita Grigoryan; Nino Keshelava; Clarke Anderson; C Patrick Reynolds
Journal:  Methods Mol Med       Date:  2005

4.  Impact of cryopreservation on B cell chronic lymphocytic leukaemia phenotype.

Authors:  V Deneys; V Thiry; N Hougardy; A M Mazzon; P Leveugle; M De Bruyère
Journal:  J Immunol Methods       Date:  1999-08-31       Impact factor: 2.303

5.  Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplification.

Authors:  Shahab Asgharzadeh; Roger Pique-Regi; Richard Sposto; Hong Wang; Yujun Yang; Hiroyuki Shimada; Katherine Matthay; Jonathan Buckley; Antonio Ortega; Robert C Seeger
Journal:  J Natl Cancer Inst       Date:  2006-09-06       Impact factor: 13.506

Review 6.  Metabolic symbiosis in cancer: refocusing the Warburg lens.

Authors:  Erica C Nakajima; Bennett Van Houten
Journal:  Mol Carcinog       Date:  2012-01-06       Impact factor: 4.784

Review 7.  Why do cancers have high aerobic glycolysis?

Authors:  Robert A Gatenby; Robert J Gillies
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

8.  Cryopreservation modifies flow-cytometric analysis of hemopoietic cells.

Authors:  M C Rosillo; F Ortuño; J Rivera; J M Moraleda; V Vicente
Journal:  Vox Sang       Date:  1995       Impact factor: 2.144

9.  Selective toxicity of 6-hydroxydopamine and ascorbate for human neuroblastoma in vitro: a model for clearing marrow prior to autologous transplant.

Authors:  C P Reynolds; D A Reynolds; E P Frenkel; R G Smith
Journal:  Cancer Res       Date:  1982-04       Impact factor: 12.701

10.  The haplotype-resolved genome and epigenome of the aneuploid HeLa cancer cell line.

Authors:  Andrew Adey; Joshua N Burton; Jacob O Kitzman; Joseph B Hiatt; Alexandra P Lewis; Beth K Martin; Ruolan Qiu; Choli Lee; Jay Shendure
Journal:  Nature       Date:  2013-08-08       Impact factor: 49.962

View more
  2 in total

1.  Modulation of Glucocorticoid Resistance in Pediatric T-cell Acute Lymphoblastic Leukemia by Increasing BIM Expression with the PI3K/mTOR Inhibitor BEZ235.

Authors:  Connor P Hall; C Patrick Reynolds; Min H Kang
Journal:  Clin Cancer Res       Date:  2015-06-16       Impact factor: 12.531

2.  A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma.

Authors:  Judith G Villablanca; Samuel L Volchenboum; Hwangeui Cho; Min H Kang; Susan L Cohn; Clarke P Anderson; Araz Marachelian; Susan Groshen; Denice Tsao-Wei; Katherine K Matthay; John M Maris; Charlotte E Hasenauer; Scarlett Czarnecki; Hollie Lai; Fariba Goodarzian; Hiro Shimada; Charles Patrick Reynolds
Journal:  Pediatr Blood Cancer       Date:  2016-04-19       Impact factor: 3.167

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.